Treatment Registry
TR-0216 ActiveRecorded September 2026

Unspecified GLP-1

Sold by T2D.com · every unspecified glp-1 record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Recorded initial charges

First month

$170

first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.

Medication · Use Our Prescribers - Monthly, All-Inclusive · recorded initial monthly payment$170

Added from the figures recorded below.

Price

TermPer monthCharged today
Use Our Prescribers - Monthly, All-Inclusive

“Includes Prescriber & Continued Patient Support Fast Onboarding No Contracts, Cancel Anytime $170/month All-Inclusive”

Per month$170Charged today$170
Price sources
Visit T2D.com

We earn nothing from this link. It opens T2D.com's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PrescriberBoth
CancellationYou can cancel a Subscription by visiting your "Account" on the Services. You will be responsible for all Subscription Fees incurred for the then-current Subscription period.

Not yet checked: pharmacy, states, membership and consult fee.

Recorded from t2d.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — T2D.com never names the drug for its main 'Use Our Prescribers' plan on the pricing block (elsewhere the site says it offers compounded Semaglutide and Tirzepatide generally), so that $170/mo entry is recorded as unspecified GLP-1. Form (vial vs pen) is never stated. About-us and contact-us paths 404'd; /pricing, /faq and /plans also 404'd -- pricing lives at /weight-loss instead.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0216
Medication category
unspecified GLP-1
Readings
1

Related records

Other records from T2D.com

All T2D.com programs and terms

Unspecified GLP-1 at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 73 records of the same molecule.

Cite this entry

Treatment Registry. (2026). T2D.com — unspecified GLP-1 (TR-0216). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0216

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.